GlassScriptPhysician profile
Joseph L Thomas
NPI 1568641660
$44,134.39
in general payments reported to CMS, 2019-2025
43 companies · $4,402 in 2025
The $4,402 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,474 · 2020: $1,618 · 2021: $5,084 · 2022: $12K · 2023: $8,170 · 2024: $7,286 · 2025: $4,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $7,545 · Grant: $125 · Gift: $36.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,151.22 |
| Consulting Fee | $7,545.00 |
| Grant | $125.00 |
| Gift | $36.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $10,365.77 | 2019-2023 | Cardiosave Hybrid, Type B Plug |
| Abbott Laboratories | $6,556.71 | 2019-2025 | Coroflow, Xience Skypoint, Mitraclip |
| Medtronic, INC. | $6,200.53 | 2021-2025 | Micra, Pulseselect, Epsila Ev |
| Boston Scientific Corporation | $5,011.83 | 2019-2025 | Avvigo Guidance System, Rotapro, Synergy |
| Maquet Cardiovascular L.L.C. | $3,300.00 | 2024 | Rotaflow |
| Datascope Corp. | $2,878.09 | 2021-2022 | |
| Csl Behring | $2,275.48 | 2023-2025 | Kcentra |
| Shockwave Medical, INC | $1,230.08 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,083.50 | 2019-2025 | Impella |
| Aop Health US, LLC | $839.36 | 2025 | Rapiblyk |
| Edwards Lifesciences Corporation | $467.50 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $450.00 | 2020 | |
| Pfizer INC. | $435.67 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $353.08 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.33 | 2019-2025 | Lifevest |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $260.90 | 2019-2024 | |
| Medtronic Vascular, INC. | $249.81 | 2019-2020 | |
| Amgen INC. | $231.21 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $223.59 | 2022-2025 | Wainua, Andexxa |
| Philips North America LLC | $153.51 | 2020-2023 | |
| Chiesi USA, INC. | $127.12 | 2020-2025 | Kengreal |
| Inari Medical, INC. | $125.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Scpharmaceuticals INC. | $109.23 | 2024-2025 | |
| Terumo Medical Corporation | $105.45 | 2019-2025 | Angio-Seal, Tr Band |
| Astellas Pharma US INC | $103.12 | 2019-2022 | |
| Teleflex LLC | $99.28 | 2019-2023 | Vascband |
| Heartflow, INC. | $97.73 | 2022-2023 | Ffrct |
| Novo Nordisk INC | $85.13 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $59.27 | 2025 | Evkeeza |
| Actelion Pharmaceuticals US, INC. | $58.76 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $49.29 | 2024 | Arcalyst |
| Z-Medica, LLC | $45.60 | 2020 | |
| Invivyd INC | $31.36 | 2025 | Pemgarda |
| Ardelyx, INC. | $30.33 | 2025 | Ibsrela |
| United Therapeutics Corporation | $23.45 | 2023 | Tyvaso |
| Merck Sharp & Dohme LLC | $19.13 | 2025 | Verquvo |
| Bridgebio Pharma, INC. | $18.94 | 2025 | Attruby |
| Ge Healthcare | $16.59 | 2020 | |
| Mylan Specialty L.P. | $16.32 | 2019 | |
| Lantheus Medical Imaging, INC. | $16.13 | 2019 | |
| Cardiva Medical, INC. | $15.21 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.